Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Isolated from 2009 to 2013 in the Republic of Ireland

about

Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Isolated from 2009 to 2013 in the Republic of Ireland

Item

http://www.wikidata.org/entity/Q57970428

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Potential Coverage of the 4CMe ...... 013 in the Republic of Ireland

@en

Potential Coverage of the 4CMe ...... 013 in the Republic of Ireland

@nl

type

Item

label

Potential Coverage of the 4CMe ...... 013 in the Republic of Ireland

@en

Potential Coverage of the 4CMe ...... 013 in the Republic of Ireland

@nl

prefLabel

Potential Coverage of the 4CMe ...... 013 in the Republic of Ireland

@en

Potential Coverage of the 4CMe ...... 013 in the Republic of Ireland

@nl

P1476

Potential Coverage of the 4CMe ...... 013 in the Republic of Ireland

@en

P2093

Desiree Bennett

http://www.w3.org/2001/XMLSchema#string

Jamie Findlow

http://www.w3.org/2001/XMLSchema#string

Jay Lucidarme

http://www.w3.org/2001/XMLSchema#string

Laura Serino

http://www.w3.org/2001/XMLSchema#string

Maria Stella

http://www.w3.org/2001/XMLSchema#string

Monica Moschioni

http://www.w3.org/2001/XMLSchema#string

Ray Borrow

http://www.w3.org/2001/XMLSchema#string

Robert Cunney

http://www.w3.org/2001/XMLSchema#string

Robert M Mulhall

http://www.w3.org/2001/XMLSchema#string

P2860

Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms

MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine

Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine

Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development.

BIGSdb: Scalable analysis of bacterial genome variation at the population level.

Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.

Using the Velvet de novo assembler for short-read sequencing technologies.

Neisseria meningitidis is structured in clades associated with restriction modification systems that modulate homologous recombination.

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines.

Bexsero® chronicle.

P31

scholarly article

P356

10.1128/MSPHERE.00196-18

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30135218

http://www.w3.org/2001/XMLSchema#string

P932

6106058

http://www.w3.org/2001/XMLSchema#string